Add Formweb to your mobile device
Search results for:
risperiDONE
risperiDONE
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| RisperDAL Consta | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 12.5 mg/2 weeks | |
| RisperDAL Consta | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 25 mg/2 weeks | |
| RisperDAL Consta | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 37.5 mg/2 weeks | |
| RisperDAL Consta | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 50 mg/2 weeks | |
| RisperiDONE | SOLUTION, ORAL | 1 mg/mL | |
| RisperiDONE | TABLET, DISINTEGRATING, ORAL | 0.5 mg | |
| RisperiDONE | TABLET, DISINTEGRATING, ORAL | 1 mg | |
| RisperiDONE | TABLET, DISINTEGRATING, ORAL | 2 mg | |
| RisperiDONE | TABLET, ORAL | 0.5 mg | |
| RisperiDONE | TABLET, ORAL | 1 mg | |
| RisperiDONE | TABLET, ORAL | 2 mg | |
| RisperiDONE | TABLET, ORAL | 3 mg | |
| RisperiDONE | TABLET, ORAL | 4 mg |
Last updated: Apr. 1, 2022
- Black Box Warning: Elderly patients with dementia related psychosis
Risperidone
Use for delerium in a ventilated Critical Care patient: See Guideline 901.5008